WEKO3
アイテム
{"_buckets": {"deposit": "2c284e2d-6edb-4836-ba61-95327fadc870"}, "_deposit": {"created_by": 15, "id": "2000719", "owner": "15", "owners": [15], "owners_ext": {"displayname": "miuse担当者2", "username": "miuse2"}, "pid": {"revision_id": 0, "type": "depid", "value": "2000719"}, "status": "published"}, "_oai": {"id": "oai:mie-u.repo.nii.ac.jp:02000719", "sets": ["1694066935734"]}, "author_link": [], "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2023-12-20", "bibliographicIssueDateType": "Issued"}}]}, "item_7_date_granted_59": {"attribute_name": "学位授与年月日", "attribute_value_mlt": [{"subitem_dategranted": "2023-12-20"}]}, "item_7_degree_grantor_57": {"attribute_name": "学位授与機関", "attribute_value_mlt": [{"subitem_degreegrantor": [{"subitem_degreegrantor_name": "三重大学"}], "subitem_degreegrantor_identifier": [{"subitem_degreegrantor_identifier_name": "14101", "subitem_degreegrantor_identifier_scheme": "kakenhi"}]}]}, "item_7_degree_name_56": {"attribute_name": "学位名", "attribute_value_mlt": [{"subitem_degreename": "博士(医学)"}]}, "item_7_description_14": {"attribute_name": "フォーマット", "attribute_value_mlt": [{"subitem_description": "application/pdf", "subitem_description_type": "Other"}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The benefits of CAR-T therapy could be expanded to the treatment of solid tumors through the use of derived autologous αβ T cell, but clinical trials of CAR-T therapy for patients with solid tumors have so far been disappointing. CAR-T therapy also faces hurdles due to the time and cost intensive preparation of CAR-T cell products derived from patients as such CAR-T cells are often poor in quality and low in quantity. These inadequacies may be mitigated through the use of third-party donor derived CAR-T cell products which have a potent anti-tumor function but a constrained GVHD property. Vγ9Vδ2 TCR have been shown to exhibit potent antitumor activity but not alloreactivity. Therefore, in this study, CAR-T cells were prepared from Vγ9Vδ2 T (CAR-γδT) cells which were expanded by using a novel prodrug PTA. CAR-γδT cells suppressed tumor growth in an antigen specific manner but only during a limited time window. Provision of GITR co-stimulation enhanced anti-tumor function of CAR-γδT cells. Our present results indicate that, while further optimization of CAR-γδ T cells is necessary, the present results demonstrate that Vγ9Vδ2 T cells are potential source of ‘off-the-shelf’ CAR-T cell products for successful allogeneic adoptive immunotherapy.", "subitem_description_language": "en", "subitem_description_type": "Abstract"}]}, "item_7_description_5": {"attribute_name": "内容記述", "attribute_value_mlt": [{"subitem_description": "本文/Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan", "subitem_description_type": "Other"}, {"subitem_description": "26p", "subitem_description_type": "Other"}]}, "item_7_dissertation_number_60": {"attribute_name": "学位授与番号", "attribute_value_mlt": [{"subitem_dissertationnumber": "甲医学第2230号"}]}, "item_7_publisher_30": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "三重大学"}]}, "item_7_relation_11": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.3390/ijms241310873", "subitem_relation_type_select": "DOI"}}]}, "item_7_text_31": {"attribute_name": "出版者(ヨミ)", "attribute_value_mlt": [{"subitem_text_value": "ミエダイガク"}]}, "item_7_text_63": {"attribute_name": "ノート", "attribute_value_mlt": [{"subitem_text_value": "International Journal of Molecular Sciences 2023, 24, 10873に掲載"}]}, "item_7_text_65": {"attribute_name": "資源タイプ(三重大)", "attribute_value_mlt": [{"subitem_text_value": "Doctoral Dissertation / 博士論文"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "open access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_abf2"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Wang, Yizheng", "creatorNameLang": "en"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_access", "date": [{"dateType": "Available"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "2023DM1212.pdf", "filesize": [{"value": "3.1 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "mimetype": "application/pdf", "size": 3100000.0, "url": {"label": "2023DM1212", "objectType": "fulltext", "url": "https://mie-u.repo.nii.ac.jp/record/2000719/files/2023DM1212.pdf"}, "version_id": "8d1e745f-ffd0-474b-8f6c-1f13220d25ce"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Vγ9Vδ2 T Cell", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "chimeric antigen receptor (CAR)", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "carcinoembryonic antigen (CEA)", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "graftversus- host disease (GVHD)", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "off-the-shelf", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "glucocorticoid-induced TNFR-related protein (GITR)", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "tetrakis-pivaloyloxymethyl 2-(thiazole-2-ylamino)ethylidene-1,1-bisphosphonate (PTA)", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "doctoral thesis", "resourceuri": "http://purl.org/coar/resource_type/c_db06"}]}, "item_title": "CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "15", "path": ["1694066935734"], "permalink_uri": "http://hdl.handle.net/10076/0002000719", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2024-04-15"}, "publish_date": "2024-04-15", "publish_status": "0", "recid": "2000719", "relation": {}, "relation_version_is_last": true, "title": ["CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy"], "weko_shared_id": -1}
CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy
http://hdl.handle.net/10076/0002000719
http://hdl.handle.net/10076/0002000719c5e0cfed-14d8-4983-ba5d-4d8ed3eb074b
名前 / ファイル | ライセンス | アクション |
---|---|---|
2023DM1212 (3.1 MB)
|
|
Item type | 学位論文 / Thesis or Dissertation(1) | |||||||
---|---|---|---|---|---|---|---|---|
公開日 | 2024-04-15 | |||||||
タイトル | ||||||||
言語 | en | |||||||
タイトル | CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy | |||||||
言語 | ||||||||
言語 | eng | |||||||
キーワード | ||||||||
言語 | en | |||||||
主題Scheme | Other | |||||||
主題 | Vγ9Vδ2 T Cell | |||||||
キーワード | ||||||||
言語 | en | |||||||
主題Scheme | Other | |||||||
主題 | chimeric antigen receptor (CAR) | |||||||
キーワード | ||||||||
言語 | en | |||||||
主題Scheme | Other | |||||||
主題 | carcinoembryonic antigen (CEA) | |||||||
キーワード | ||||||||
言語 | en | |||||||
主題Scheme | Other | |||||||
主題 | graftversus- host disease (GVHD) | |||||||
キーワード | ||||||||
言語 | en | |||||||
主題Scheme | Other | |||||||
主題 | off-the-shelf | |||||||
キーワード | ||||||||
言語 | en | |||||||
主題Scheme | Other | |||||||
主題 | glucocorticoid-induced TNFR-related protein (GITR) | |||||||
キーワード | ||||||||
言語 | en | |||||||
主題Scheme | Other | |||||||
主題 | tetrakis-pivaloyloxymethyl 2-(thiazole-2-ylamino)ethylidene-1,1-bisphosphonate (PTA) | |||||||
資源タイプ | ||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_db06 | |||||||
資源タイプ | doctoral thesis | |||||||
アクセス権 | ||||||||
アクセス権 | open access | |||||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||
著者 |
Wang, Yizheng
× Wang, Yizheng
|
|||||||
抄録 | ||||||||
内容記述タイプ | Abstract | |||||||
内容記述 | The benefits of CAR-T therapy could be expanded to the treatment of solid tumors through the use of derived autologous αβ T cell, but clinical trials of CAR-T therapy for patients with solid tumors have so far been disappointing. CAR-T therapy also faces hurdles due to the time and cost intensive preparation of CAR-T cell products derived from patients as such CAR-T cells are often poor in quality and low in quantity. These inadequacies may be mitigated through the use of third-party donor derived CAR-T cell products which have a potent anti-tumor function but a constrained GVHD property. Vγ9Vδ2 TCR have been shown to exhibit potent antitumor activity but not alloreactivity. Therefore, in this study, CAR-T cells were prepared from Vγ9Vδ2 T (CAR-γδT) cells which were expanded by using a novel prodrug PTA. CAR-γδT cells suppressed tumor growth in an antigen specific manner but only during a limited time window. Provision of GITR co-stimulation enhanced anti-tumor function of CAR-γδT cells. Our present results indicate that, while further optimization of CAR-γδ T cells is necessary, the present results demonstrate that Vγ9Vδ2 T cells are potential source of ‘off-the-shelf’ CAR-T cell products for successful allogeneic adoptive immunotherapy. | |||||||
言語 | en | |||||||
内容記述 | ||||||||
内容記述タイプ | Other | |||||||
内容記述 | 本文/Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan | |||||||
内容記述 | ||||||||
内容記述タイプ | Other | |||||||
内容記述 | 26p | |||||||
書誌情報 |
発行日 2023-12-20 |
|||||||
DOI | ||||||||
識別子タイプ | DOI | |||||||
関連識別子 | 10.3390/ijms241310873 | |||||||
フォーマット | ||||||||
内容記述タイプ | Other | |||||||
内容記述 | application/pdf | |||||||
出版者 | ||||||||
出版者 | 三重大学 | |||||||
出版者(ヨミ) | ||||||||
ミエダイガク | ||||||||
学位名 | ||||||||
学位名 | 博士(医学) | |||||||
学位授与機関 | ||||||||
学位授与機関識別子Scheme | kakenhi | |||||||
学位授与機関識別子 | 14101 | |||||||
学位授与機関名 | 三重大学 | |||||||
学位授与年月日 | ||||||||
学位授与年月日 | 2023-12-20 | |||||||
学位授与番号 | ||||||||
学位授与番号 | 甲医学第2230号 | |||||||
ノート | ||||||||
International Journal of Molecular Sciences 2023, 24, 10873に掲載 | ||||||||
資源タイプ(三重大) | ||||||||
Doctoral Dissertation / 博士論文 |